Filing Details
- Accession Number:
- 0001209191-22-023656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-07 16:12:48
- Reporting Period:
- 2022-04-05
- Accepted Time:
- 2022-04-07 16:12:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1290149 | Sierra Oncology Inc. | SRRA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1819688 | D. William Turner | C/O Sierra Oncology, Inc. 1820 Gateway Drive, Suite 110 San Mateo CA 94404 | Chief Reg & Tech Ops Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-05 | 100 | $12.05 | 100 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-05 | 100 | $37.09 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-06 | 6,347 | $12.05 | 6,347 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-06 | 6,347 | $37.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-04-05 | 100 | $0.00 | 100 | $12.05 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-04-06 | 6,347 | $0.00 | 6,347 | $12.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-08-04 | No | 4 | M | Direct | |
| 0 | 2030-08-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2021. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on April 26, 2022. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- On August 4, 2021, the option vested as to 25% of the total shares granted on August 4, 2020, with the remaining shares from that grant vesting in equal monthly installments over the following 36 months, with 100% of the total shares vested on August 4, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Billionaire Hedge Funds
